182 related articles for article (PubMed ID: 9591593)
21. The effect of steroid on thallium-201 uptake by malignant gliomas.
Namba H; Togawa T; Yui N; Yanagisawa M; Kinoshita F; Iwadate Y; Ohsato K; Sueyoshi K
Eur J Nucl Med; 1996 Aug; 23(8):991-2. PubMed ID: 8753692
[TBL] [Abstract][Full Text] [Related]
22. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
[TBL] [Abstract][Full Text] [Related]
23. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.
Roelcke U; Radü EW; von Ammon K; Hausmann O; Maguire RP; Leenders KL
J Neurol Sci; 1995 Sep; 132(1):20-7. PubMed ID: 8523026
[TBL] [Abstract][Full Text] [Related]
24. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
25. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
26. Reproducibility of metabolic measurements in malignant tumors using FDG PET.
Weber WA; Ziegler SI; Thödtmann R; Hanauske AR; Schwaiger M
J Nucl Med; 1999 Nov; 40(11):1771-7. PubMed ID: 10565769
[TBL] [Abstract][Full Text] [Related]
27. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
[TBL] [Abstract][Full Text] [Related]
28. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
29. Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain.
Claeys J; Mertens K; D'Asseler Y; Goethals I
Ann Nucl Med; 2010 Jul; 24(6):501-5. PubMed ID: 20237872
[TBL] [Abstract][Full Text] [Related]
30. FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies.
Diederichs CG; Staib L; Glatting G; Beger HG; Reske SN
J Nucl Med; 1998 Jun; 39(6):1030-3. PubMed ID: 9627339
[TBL] [Abstract][Full Text] [Related]
31. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
32. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
33. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy.
Würker M; Herholz K; Voges J; Pietrzyk U; Treuer H; Bauer B; Sturm V; Heiss WD
Eur J Nucl Med; 1996 May; 23(5):583-6. PubMed ID: 8698067
[TBL] [Abstract][Full Text] [Related]
34. [Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].
Oehr P; Ruhlmann J; Kozak B; Brock H; Thieme D; Rink H
Acta Med Austriaca; 1999; 26(3):101-3. PubMed ID: 10520378
[TBL] [Abstract][Full Text] [Related]
35. 2-[C-11]thymidine imaging of malignant brain tumors.
Eary JF; Mankoff DA; Spence AM; Berger MS; Olshen A; Link JM; O'Sullivan F; Krohn KA
Cancer Res; 1999 Feb; 59(3):615-21. PubMed ID: 9973209
[TBL] [Abstract][Full Text] [Related]
36. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
37. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Rozental JM; Levine RL; Nickles RJ; Dobkin JA
Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
[TBL] [Abstract][Full Text] [Related]
38. Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.
Lindholm P; Minn H; Leskinen-Kallio S; Bergman J; Ruotsalainen U; Joensuu H
J Nucl Med; 1993 Jan; 34(1):1-6. PubMed ID: 8418248
[TBL] [Abstract][Full Text] [Related]
39. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
Cook GJ; Houston S; Barrington SF; Fogelman I
J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
[TBL] [Abstract][Full Text] [Related]
40. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]